Today: 22 May 2026
Browse Category

BSE:532365 12 December 2025 - 13 December 2025

Dynacons Systems & Solutions (DSSL) stock jumps on ₹74.99‑crore J&K Bank DaaS win: share price, latest news, earnings and forecasts (Dec 13, 2025)

Dynacons Systems & Solutions (DSSL) stock jumps on ₹74.99‑crore J&K Bank DaaS win: share price, latest news, earnings and forecasts (Dec 13, 2025)

Dynacons Systems & Solutions shares jumped 13.34% to ₹978.80 on Friday after announcing a ₹74.99-crore Device-as-a-Service contract from Jammu & Kashmir Bank. The stock saw heavy trading and wide intraday swings, hitting a high of ₹998.5 before closing well below its 52-week peak of ₹1,618.20.
13 December 2025
···
Dynacons Systems & Solutions Stock Surges on ₹74.99 Crore J&K Bank DaaS Deal: DSSL Share Price, News, Forecasts and Technical Outlook (Dec 12, 2025)

Dynacons Systems & Solutions Stock Surges on ₹74.99 Crore J&K Bank DaaS Deal: DSSL Share Price, News, Forecasts and Technical Outlook (Dec 12, 2025)

Dynacons Systems & Solutions shares surged on December 12 after announcing a ₹74.99 crore Device-as-a-Service contract with Jammu & Kashmir Bank. The five-year deal covers nearly 10,000 desktops across 1,019 branches nationwide. The company stated the contract is not a related-party transaction. The stock saw a sharp rise following the disclosure.
12 December 2025
···

Stock Market Today

  • NYSE's Martin Questions Nasdaq Rules Attracting SpaceX IPO
    May 22, 2026, 9:22 AM EDT. Lynn Martin, President of the New York Stock Exchange (NYSE), criticized some of the Nasdaq's listing rules used to attract SpaceX's public offering as "questionable." Speaking on Bloomberg Surveillance, Martin emphasized that market integrity should not be compromised for competitive gains between stock exchanges. She noted 2023 has been a strong year for initial public offerings (IPOs) across sectors and affirmed the NYSE's commitment to bringing more companies public. Martin's remarks highlight ongoing debates over regulatory standards and competitive practices in the IPO market.

Latest articles

Akari Therapeutics Stock Is Soaring Again — The KRAS Cancer Data Behind the Move

Akari Therapeutics Stock Is Soaring Again — The KRAS Cancer Data Behind the Move

22 May 2026
Akari Therapeutics shares more than doubled in premarket trading Friday after its lead cancer drug showed positive preclinical results in KRAS-mutated pancreatic cancer models and the company announced a $5.5 million private placement. The stock was quoted at $10.15, up from Thursday’s $5.14 close. Akari plans to start Phase 1 human trials of AKTX-101 by mid-2027. The company reported $2.8 million in cash at March 31.
BMO Lands Buy Rating Ahead of Earnings But Targets Raise Questions

BMO Lands Buy Rating Ahead of Earnings But Targets Raise Questions

22 May 2026
Canaccord Genuity reaffirmed a Buy rating on Bank of Montreal ahead of its May 27 earnings report. BMO shares closed May 21 at C$220.06, near a 52-week high and up 23.5% year-to-date. The bank recently agreed to sell C$14.5 billion in loan and lease assets to Stonepeak, expecting a CET1 ratio boost but a C$900 million after-tax charge. Analyst consensus remains mixed, with most holding or selling.
Atmos Energy’s run in Texas faces new Wall Street target cut

Atmos Energy’s run in Texas faces new Wall Street target cut

22 May 2026
Morgan Stanley lowered its Atmos Energy price target to $183 from $195, maintaining an Equalweight rating. The move follows Atmos’ recent increase in its 2026 earnings outlook and annual dividend. Atmos shares closed at $177.46 on Thursday. Texas remains central to Atmos’ growth and regulatory strategy, with 65% of its rate base in the state.
Go toTop